United States

Pfizer Inc (PFE)

PFE on New York Consolidated

20 Jan 2017
Change (% chg)

$0.07 (+0.22%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Pfizer completes acquisition of small molecule anti-infective business from AstraZeneca
Friday, 23 Dec 2016 02:05am EST 

Pfizer Inc : Says completed acquisition of development rights to Astrazeneca's late-stage anti-infective business, primarily outside united states .Pfizer completes acquisition of small molecule anti-infective business from Astrazeneca.  Full Article

Ab Initio Biotherapeutics announces strategic collaboration with Pfizer to discover GPCR activating antibodies
Tuesday, 13 Dec 2016 01:03pm EST 

Ab Initio Biotherapeutics Inc: Ab Initio - addition of will somers, ph.d., vice president of biomedicines design at pfizer, to ab initio scientific advisory board . Ab Initio - ab initio will receive an upfront fee and research support . Ab Initio - co is eligible to receive milestone payments and tiered royalties on future sales of any products that may result from the collaboration . Ab Initio -pfizer has exclusive worldwide rights to develop,commercialize gpcr activator antibodies against this target that may result from deal . Ab Initio biotherapeutics - further terms of deal are not disclosed . Ab Initio biotherapeutics - in addition, pfizer will make a strategic investment in ab initio alongside company's existing investors . Ab Initio biotherapeutics - addition of will somers, vice president of biomedicines design at pfizer, to ab initio scientific advisory board .Ab Initio announces strategic collaboration with pfizer to discover gpcr activating antibodies.  Full Article

Drugmakers trade group says government mandates wrong way to address drug costs
Wednesday, 7 Dec 2016 12:15pm EST 

U.S. drugmakers trade group PhRMA, in response to President-Elect Trump statement that he will bring down drug prices: PhRMA says government mandates, interventions are not right means of addressing prescription drug costs . Trade group says looking forward to working with Trump Administration next year to enhance competitive private market, ensure drug access .Trade group statement follows comment from Trump in Time Magazine interview that he will "bring down drug prices".  Full Article

Pfizer to appeal all aspects of decision by UK's CMA
Wednesday, 7 Dec 2016 02:27am EST 

Pfizer : Says refutes UK Competition and Markets Authority decision, will be appealing all aspects of the decision Further company coverage: [PFE.N] (Reporting by UK bureau) ((uk.online@reuters.com;)).  Full Article

UK's CMA fines Pfizer, Flynn Pharma for epilepsy drug price hike
Wednesday, 7 Dec 2016 02:18am EST 

UK's Competition and Markets Authority (CMA) : Fines Pfizer and Flynn 90 million stg for drug price hike to NHS . Imposed a 84.2 million stg fine on Pfizer, and 5.2 million stg fine on the distributor Flynn Pharma . Fines companies after finding that each broke competition law by charging excessive, unfair prices in UK for phenytoin sodium capsules . Fines follow prices increasing by up to 2,600 percent overnight after the drug was deliberately de-branded in September 2012 . To ensure no risk to ongoing supply of phenytoin sodium capsules CMA has given companies between 30 working days and 4 months to cut prices . Has also ordered the companies to reduce their prices. ."Prices of the drug in the UK have also been many times higher than Pfizer’s prices for the same drug in any other European countries".  Full Article

Pfizer's pain drug Lyrica meets goal in late-stage pediatric epilepsy study
Thursday, 1 Dec 2016 08:00am EST 

Pfizer Inc: lyrica® (pregabalin) phase 3 trial in pediatric epilepsy meets primary endpoint .Lyrica is not approved as adjunctive therapy for pediatric epilepsy patients with partial onset seizures.  Full Article

Pfizer Inc, IBM announced a collaboration that will utilize IBM watson for drug discovery
Thursday, 1 Dec 2016 08:00am EST 

Pfizer Inc : Ibm and pfizer to accelerate immuno-oncology research with watson for drug discovery .Pfizer inc - co, IBM announced a collaboration that will utilize ibm watson for drug discovery to help "accelerate" pfizer's research in immuno-oncology.  Full Article

Pfizer says Pfizer Global Supply President to retire
Monday, 21 Nov 2016 10:11am EST 

Pfizer Inc : Anthony J. Maddaluna, executive vice president and president of Pfizer Global Supply to retire .Kirsten Lund-Jurgensen will succeed Maddaluna and has been named EVP and president of Pfizer Global Supply, effective December 30, 2016.  Full Article

Pfizer announces pricing of tender offer for any and all of its 6.200 pct senior notes due March 15, 2019
Friday, 18 Nov 2016 02:55pm EST 

Pfizer Inc :Pfizer announces pricing of tender offer for any and all of its 6.200 pct senior notes due March 15, 2019.  Full Article

Paulson & Co cuts share stake in Pfizer, raises share stake in Facebook
Monday, 14 Nov 2016 05:35pm EST 

Paulson & Co Inc : Paulson & Co Inc raises share stake in Facebook Inc by 47.3 percent to 212,700 Class A shares . Paulson & Co Inc cuts share stake in Pfizer Inc by 50.6 percent to 252,000 shares - SEC filing . Paulson & Co Inc takes share stake of 45,800 shares in Eli Lilly .Paulson & Co Inc - Change in holdings are as of September 30, 2016 and compared with the previous quarter ended as of June 30, 2016.  Full Article


Sanofi's M&A misses frustrate some investors in drugmaker

PARIS/DAVOS, Switzerland For the last year, Sanofi's chief executive has made clear his quest for deals to help revive the fortunes of France's biggest drugmaker.